Bluebird's newly approved SCD gene therapy faces rough road with hefty price tag, boxed warning-- How Kyowa Kirin is giving employees a voice in the company's future --Moderna, Merck begin late-stage study for mRNA cancer therapy --http://bit.ly/w28kSd #bluebirdbio #sicklecelldisease #kyowakirin #merck #moderna #cancer #mRNA #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Pfizer plans to shutter New Jersey campus, discloses layoffs amid $3.5B cost-cutting drive-- Bluebird bio to sell sickle cell FDA voucher for $103 mln if therapy approved --GSK's Jemperli prolongs life in endometrial cancer trial-- See more on our front page news http://bit.ly/w28kSd #pfizer #layoffs #newjersey #bluebirdbio #fda #sicklecelldisease #gsk #clinicaltrials #endometrialcancer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma